NEW YORK (GenomeWeb) – MDxHealth today announced an agreement with preferred provider organization Galaxy Health Network to provide access to MDxHealth's ConfirmMDx for Prostate Cancer test.

Based in Arlington, Texas, Galaxy has a provider network of more than 400,000 physicians, 2,700 hospitals, and 47,000 ancillary providers, as well as more than 3.5 million covered lives. Today's agreement brings the total number of covered lives with access to ConfirmMDx to about 147 million in the US, MDxHealth said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.